Bristol Myers Squibb (CELG-RI) Share-based Compensation (QoQ) (2009 - 2026)

Bristol Myers Squibb (CELG-RI) Share-based Compensation (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.77%
Dec 31, 2025 -4.32%
Sep 30, 2025 1.46%
Jun 30, 2025 -4.86%
Mar 31, 2025 20.00%
Dec 31, 2024 -6.98%
Sep 30, 2024 3.20%
Jun 30, 2024 -6.02%
Mar 31, 2024 4.72%
Dec 31, 2023 -3.79%
Sep 30, 2023 -3.65%
Jun 30, 2023 12.30%
Mar 31, 2023 2.52%
Dec 31, 2022 3.48%
Sep 30, 2022 -0.86%
Jun 30, 2022 8.41%
Mar 31, 2022 -19.55%
Dec 31, 2021 -6.34%
Sep 30, 2021 -9.55%
Jun 30, 2021 3.97%